The table below shows Roivant Sciences Ltd.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q4 2025
Q3 2025
Q2 2025
Q4 2024
Q3 2024
Q2 2024
Revenue
$2.00M
$1.57M
$2.17M
$9.02M
$4.47M
$7.99M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$165.38M
$164.57M
$152.92M
$141.59M
$143.07M
$120.51M
SG&A
ROIV annual revenue (10-K history)
Roivant Sciences Ltd. reported annual revenue of $8.26M for fiscal year 2026. That is down 71.6% from $29.05M in fiscal 2025. Over the 6 fiscal years shown, annual revenue declined from $23.80M (FY 2021) to $8.26M. Figures come from the company's audited annual reports as filed with the SEC.
